Improving Bladder Cancer Imaging Using 3-T Functional Dynamic Contrast-Enhanced Magnetic Resonance Imaging
暂无分享,去创建一个
Huyen T. X. Nguyen | M. Knopp | G. Jia | Lai Wei | Z. Shah | D. Zynger | A. Mortazavi | K. Pohar | Xiangyu Yang | D. Clark
[1] P. Bendahl,et al. Preoperative staging of locally advanced bladder cancer before radical cystectomy using 3 tesla magnetic resonance imaging with a standardized protocol , 2013, Scandinavian journal of urology.
[2] S. Sourbron,et al. Interscanner Comparison of Dynamic Contrast-Enhanced MRI in Prostate Cancer: 1.5 Versus 3 T MRI , 2013, Investigative radiology.
[3] M. Amin,et al. The diagnostic accuracy of multidetector computed tomography with multiplanar reformatted imaging and virtual cystoscopy in the early detection and evaluation of bladder carcinoma: comparison with conventional cystoscopy , 2013, Abdominal Imaging.
[4] S. Horenblas,et al. Catheter-assisted 18F-FDG-PET/CT imaging of primary bladder cancer: a prospective study , 2012, Nuclear medicine communications.
[5] A. Graser,et al. Interobserver variability limits exact preoperative staging by computed tomography in bladder cancer. , 2012, Urology.
[6] Maximilian Reiser,et al. Quantification of Perfusion and Permeability in Multiple Sclerosis: Dynamic Contrast-Enhanced MRI in 3D at 3T , 2012, Investigative radiology.
[7] Sadhna Verma,et al. Urinary bladder cancer: role of MR imaging. , 2012, Radiographics : a review publication of the Radiological Society of North America, Inc.
[8] H. Sostman,et al. Comparison of 1.5 and 3.0 T for Contrast-Enhanced Pulmonary Magnetic Resonance Angiography , 2012, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[9] P. Lara,et al. Progress in Personalizing Chemotherapy for Bladder Cancer , 2012, Advances in urology.
[10] C. Nicolau,et al. Accuracy of contrast-enhanced ultrasound in the detection of bladder cancer. , 2011, The British journal of radiology.
[11] C. Kuhl,et al. Dual-source parallel radiofrequency excitation body MR imaging compared with standard MR imaging at 3.0 T: initial clinical experience. , 2010, Radiology.
[12] Carlos Nicolau,et al. Diagnosis of bladder cancer: contrast-enhanced ultrasound , 2010, Abdominal Imaging.
[13] Maximilian F. Reiser,et al. Diffusion Tensor Imaging (DTI) of the Kidney at 3 Tesla–Feasibility, Protocol Evaluation and Comparison to 1.5 Tesla , 2010, Investigative radiology.
[14] S. Lerner. Innovations in endoscopic imaging for bladder cancer. , 2009, European urology.
[15] Y. Tokuda,et al. The effects of neoadjuvant chemotherapy and chemo-radiation therapy on MRI staging in invasive bladder cancer: comparative study based on the pathological examination of whole layer bladder wall , 2009, International Urology and Nephrology.
[16] Tarek El-Diasty,et al. Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging , 2009, European Radiology.
[17] Alvin C. Goh,et al. Application of new technology in bladder cancer diagnosis and treatment , 2009, World Journal of Urology.
[18] K. Jhaveri,et al. Magnetic resonance imaging of the urinary bladder: cancer staging and beyond. , 2008, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.
[19] Xiangyu Yang,et al. Improving the pharmacokinetic parameter measurement in dynamic contrast‐enhanced MRI by use of the arterial input function: Theory and clinical application , 2008, Magnetic resonance in medicine.
[20] N. Holalkere,et al. State-of-the-art cross-sectional imaging in bladder cancer. , 2007, Current problems in diagnostic radiology.
[21] J O Barentsz,et al. Evaluation of chemotherapy with magnetic resonance imaging in patients with regionally metastatic or unresectable bladder cancer. , 2006, European urology.
[22] S. Yun,et al. Preoperative staging of rectal cancer: accuracy of 3-Tesla magnetic resonance imaging , 2006, European Radiology.
[23] Dennis W J Klomp,et al. Initial Experience of 3 Tesla Endorectal Coil Magnetic Resonance Imaging and 1H-Spectroscopic Imaging of the Prostate , 2004, Investigative radiology.
[24] C. Matula,et al. Magnetic Resonance Imaging Contrast Enhancement of Brain Tumors at 3 Tesla Versus 1.5 Tesla , 2002, Investigative radiology.
[25] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[26] T. Mashimo,et al. Evaluation of effect of treatment for invasive bladder cancer by ultrasonography with intra-arterial infusion of carbon dioxide microbubbles. , 1997, Investigative radiology.
[27] W. J. Lorenz,et al. Pharmacokinetic Mapping of the Breast: A New Method for Dynamic MR Mammography , 1995, Magnetic resonance in medicine.
[28] D. Bluemke,et al. UROLOGICAL ONCOLOGY: BLADDER, PENIS AND URETHRAL CANCER, AND BASIC PRINCIPLES OF ONCOLOGY Dynamic MRI of Bladder Cancer: Evaluation of Staging Accuracy , 2005 .
[29] L R Schad,et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. , 1991, Journal of computer assisted tomography.